|
|
The research activities of the Section of
Rheumatology extend from laboratory based basic science investigations
to patient care initiatives aimed at improving diagnosis and treatment.
Our research laboratories enjoy excellent support from federal agencies
(such as the National Institutes of Health) and private foundations
(such as the Arthritis Foundation). The success of our research derives
from strong interactions and collaborations with other entities at The
University of Chicago interested in the prevention and treatment of
autoimmune diseases. All basic researchers in the Section of Rheumatology
are members of the Committee on Immunology, an interactive group that
comprises all faculty members of the University of Chicago with a research
interest in Immunology. The Committee on Immunology includes world-renowned
lymphocyte experts, including Albert Bendelac, the Committee’s
chairman, Harinder Singh and Ursula Storb. In addition, the basic researchers
of the Section of Rheumatology have strong ties with The University
of Chicago Knapp Center for Lupus and Immunology Research, a research
center lead by the member of the National Academy of Sciences Martin
Weigert, a leader in the field of B cell biology.
Clinical research activities of the section include the testing of
diagnostic methods and therapeutic agents developed either at The
University of Chicago or under outside auspices such as pharmaceutical
manufacturers or colleagues in the academic community nationwide.
Current and recent testing of therapies developed at The University
of Chicago includes studies aimed at modifying the course of disease
such as rheumatoid arthritis, psoriatic arthritis and scleroderma.
Patients are also involved in studies on systemic lupus, osteoarthritis,
gout and inflammatory muscle disease. |
©1998-99 The University of Chicago®